Peter Garcia
2022 - ALX ONCOLOGY HOLDINGS
In 2022, Peter Garcia earned a total compensation of $1.8M as Chief Financial Officer at ALX ONCOLOGY HOLDINGS, a 63% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $164,314 |
---|---|
Option Awards | $790,077 |
Salary | $466,800 |
Stock Awards | $332,630 |
Total | $1,753,821 |
Garcia received $790.1K in option awards, accounting for 45% of the total pay in 2022.
Garcia also received $164.3K in non-equity incentive plan, $466.8K in salary and $332.6K in stock awards.
Rankings
In 2022, Peter Garcia's compensation ranked 1,901st out of 5,387 executives tracked by ExecPay. In other words, Garcia earned more than 64.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,901 | 65th |
Manufacturing | 1,010 | 65th |
Chemicals And Allied Products | 423 | 68th |
Drugs | 386 | 68th |
Pharmaceutical Preparations | 279 | 68th |
Garcia's colleagues
We found two more compensation records of executives who worked with Peter Garcia at ALX ONCOLOGY HOLDINGS in 2022.
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019